Welcome to CDC stacks |
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Clostridium botulinum strain Af84 produces three enzymatically active neurotoxins: BoNT/A2, BoNT/F4, and BoNT/F5
Filetype[PDF-418.82 KB]


Details:
  • Alternative Title:
    Anal Chem
  • Personal Author:
  • Description:
    Botulinum neurotoxins (BoNTs) are produced by various species of clostridia and are potent neurotoxins which cause the disease botulism, by cleaving proteins needed for successful nerve transmission. There are currently seven confirmed serotypes of BoNTs, labeled A-G, and toxin-producing clostridia typically only produce one serotype of BoNT. There are a few strains (bivalent strains) which are known to produce more than one serotype of BoNT, producing either both BoNT/A and /B, BoNT/A and /F, or BoNT/B and /F, designated as Ab, Ba, Af, or Bf. Recently, it was reported that Clostridium botulinum strain Af84 has three neurotoxin gene clusters: bont/A2, bont/F4, and bont/F5. This was the first report of a clostridial organism containing more than two neurotoxin gene clusters. Using a mass spectrometry based proteomics approach, we report here that all three neurotoxins, BoNT/A2, /F4, and /F5, are produced by C. botulinum Af84. Label free MS(E) quantification of the three toxins indicated that toxin composition is 88% BoNT/A2, 1% BoNT/F4, and 11% BoNT/F5. The enzymatic activity of all three neurotoxins was assessed by examining the enzymatic activity of the neurotoxins upon peptide substrates, which mimic the toxins' natural targets, and monitoring cleavage of the substrates by mass spectrometry. We determined that all three neurotoxins are enzymatically active. This is the first report of three enzymatically active neurotoxins produced in a single strain of Clostridium botulinum.

  • Subject:
  • Pubmed ID:
    24605815
  • Pubmed Central ID:
    PMC4522913
  • Document Type:
    Journal Article
  • Funding:
    SSK7/Intramural CDC HHS/United States
  • Collection(s):
    CDC Public Access
  • Main Document Checksum:
No Related Documents.
You May Also Like:
  1. Purification and Characterization of Botulinum Neurotoxin FA from a Genetically Modified Clostridium botulinum Strain
    Personal Author:
    Pellett, Sabine; Tepp, William H.; Bradshaw, Marite; Kalb, Suzanne R.; Dykes, Janet K.; Lin, Guangyun; Nawrocki, Erin M.; Pier, Christina L.; Barr, John R.; Maslanka, Susan E.; Johnson, Eric A.;
    Published Date:
    2016 Jan-Feb
    Source:
    mSphere. 2016; 1(1).
    Description:
    Botulinum neurotoxins (BoNTs), produced by neurotoxigenic clostridial species, are the cause of the severe disease botulism in humans and animals. Early research on BoNTs has led to their classification into seven serotypes (serotypes A to G) based u...
    File Type:
    Filetype[PDF - 1.24 MB]
  2. Characterization of Hemagglutinin Negative Botulinum Progenitor Toxins
    Personal Author:
    Kalb, Suzanne R.; Baudys, Jakub; Smith, Theresa J.; Smith, Leonard A.; Barr, John R.;
    Published Date:
    Jun 15 2017
    Source:
    Toxins (Basel). 2017; 9(6).
    Description:
    Botulism is a disease involving intoxication with botulinum neurotoxins (BoNTs), toxic proteins produced by Clostridium botulinum and other clostridia. The 150 kDa neurotoxin is produced in conjunction with other proteins to form the botulinum progen...
    File Type:
    Filetype[PDF - 1.07 MB]
  3. Isolation and Functional Characterization of the Novel Clostridium botulinum Neurotoxin A8 Subtype
    Personal Author:
    Kull, Skadi; Schulz, K. Melanie; Strotmeier, Jasmin Weisemann née; Kirchner, Sebastian; Schreiber, Tanja; Bollenbach, Alexander; Dabrowski, P. Wojtek; Nitsche, Andreas; Kalb, Suzanne R.; Dorner, Martin B.; Barr, John R.; Rummel, Andreas; Dorner, Brigitte G.;
    Published Date:
    Feb 06 2015
    Source:
    PLoS One. 10(2).
    Description:
    Botulism is a severe neurological disease caused by the complex family of botulinum neurotoxins (BoNT). Based on the different serotypes known today, a classification of serotype variants termed subtypes has been proposed according to sequence divers...
    File Type:
    Filetype[PDF - 1.06 MB]
  4. Detection of the HA-33 protein in botulinum neurotoxin type G complex by mass spectrometry
    Personal Author:
    Kalb, Suzanne R.; Baudys, Jakub; Barr, John R.;
    Published Date:
    Oct 23 2015
    Source:
    BMC Microbiol. 15.
    Description:
    BackgroundThe disease botulism is caused by intoxication with botulinum neurotoxins (BoNTs), extremely toxic proteins which cause paralysis. This neurotoxin is produced by some members of the Clostridium botulinum and closely related species, and is ...
    File Type:
    Filetype[PDF - 1.25 MB]
  5. Recommended Mass Spectrometry-Based Strategies to Identify Botulinum Neurotoxin-Containing Samples
    Personal Author:
    Kalb, Suzanne R.; Baudys, Jakub; Wang, Dongxia; Barr, John R.;
    Published Date:
    May 19 2015
    Source:
    Toxins (Basel). 2015; 7(5):1765-1778.
    Description:
    Botulinum neurotoxins (BoNTs) cause the disease called botulism, which can be lethal. BoNTs are proteins secreted by some species of clostridia and are known to cause paralysis by interfering with nerve impulse transmission. Although the human lethal...
    File Type:
    Filetype[PDF - 1.01 MB]